Coexistence of systemic lupus erythematosus, tuberous sclerosis and aggressive natural killer-cell leukaemia: coincidence or correlated?

被引:17
作者
Bekkink, M. Olde [1 ]
Ahmed-Ousenkova, Y. M. [2 ]
Netea, M. G. [1 ,3 ]
van der Velden, W. J. [4 ]
Berden, J. H. [2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6500 HB Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6500 HB Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Haematol, NL-6500 HB Nijmegen, Netherlands
关键词
Haematological changes; nephritis; systemic lupus erythematosus; tuberous sclerosis; EPSTEIN-BARR-VIRUS; GRANULAR LYMPHOCYTE LEUKEMIA; EPIDEMIOLOGY; RISK; NEOPLASMS; PATHWAYS; GROWTH; CANCER;
D O I
10.1177/0961203316636466
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Among patients with systemic lupus erythematosus (SLE) there is an increased risk of haematological malignancies, especially non-Hodgkin lymphoma. However, the association of SLE with aggressive CD3 negative natural killer (NK)-cell leukaemia has not been reported so far. We present a case of a 39-year-old woman with SLE, aggressive NK-cell leukaemia and tuberous sclerosis complex. The prior probability of developing the combination of these three rare diseases by coincidence is extremely low (<10(-13)). Possible underlying immunological, genetic and toxic/environmental pathways are discussed.
引用
收藏
页码:766 / 771
页数:6
相关论文
共 32 条
[1]
An International Cohort Study of Cancer in Systemic Lupus Erythematosus [J].
Bernatsky, S ;
Boivin, JF ;
Joseph, L ;
Rajan, R ;
Zoma, A ;
Manzi, S ;
Ginzler, E ;
Urowitz, M ;
Gladman, D ;
Fortin, PR ;
Petri, M ;
Edworthy, S ;
Barr, S ;
Gordon, C ;
Bae, SC ;
Sibley, J ;
Isenberg, D ;
Rahman, A ;
Aranow, C ;
Dooley, MA ;
Steinsson, K ;
Nived, O ;
Sturfelt, G ;
Alarcón, G ;
Senécal, JL ;
Zummer, M ;
Hanly, J ;
Ensworth, S ;
Pope, J ;
El-Gabalawy, H ;
McCarthy, T ;
Pierre, YS ;
Ramsey-Goldman, R ;
Clarke, A .
ARTHRITIS AND RHEUMATISM, 2005, 52 (05) :1481-1490
[2]
Lymphoma risk in systemic lupus: effects of disease activity versus treatment [J].
Bernatsky, Sasha ;
Ramsey-Goldman, Rosalind ;
Joseph, Lawrence ;
Boivin, Jean-Francois ;
Costenbader, Karen H. ;
Urowitz, Murray B. ;
Gladman, Dafna D. ;
Fortin, Paul R. ;
Nived, Ola ;
Petri, Michelle A. ;
Jacobsen, Soren ;
Manzi, Susan ;
Ginzler, Ellen M. ;
Isenberg, David ;
Rahman, Anisur ;
Gordon, Caroline ;
Ruiz-Irastorza, Guillermo ;
Yelin, Edward ;
Bae, Sang-Cheol ;
Wallace, Daniel J. ;
Peschken, Christine A. ;
Dooley, Mary Anne ;
Edworthy, Steven M. ;
Aranow, Cynthia ;
Kamen, Diane L. ;
Romero-Diaz, Juanita ;
Askanase, Anca ;
Witte, Torsten ;
Barr, Susan G. ;
Criswell, Lindsey A. ;
Sturfelt, Gunnar K. ;
Blanco, Irene ;
Feldman, Candace H. ;
Dreyer, Lene ;
Patel, Neha M. ;
St Pierre, Yvan ;
Clarke, Ann E. .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) :138-142
[3]
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma [J].
Bouchekioua, A. ;
Scourzic, L. ;
de Wever, O. ;
Zhang, Y. ;
Cervera, P. ;
Aline-Fardin, A. ;
Mercher, T. ;
Gaulard, P. ;
Nyga, R. ;
Jeziorowska, D. ;
Douay, L. ;
Vainchenker, W. ;
Louache, F. ;
Gespach, C. ;
Solary, E. ;
Coppo, P. .
LEUKEMIA, 2014, 28 (02) :338-348
[4]
Tuberous sclerosis [J].
Curatolo, Paolo ;
Bombardieri, Roberta ;
Jozwiak, Sergiusz .
LANCET, 2008, 372 (9639) :657-668
[5]
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden [J].
Danchenko, N ;
Satia, J ;
Anthony, M .
LUPUS, 2006, 15 (05) :308-318
[6]
Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients [J].
Draborg, Anette Holck ;
Jacobsen, Soren ;
Westergaard, Marie ;
Mortensen, Shila ;
Larsen, Janni Lisander ;
Houen, Gunnar ;
Duus, Karen .
LUPUS SCIENCE & MEDICINE, 2014, 1 (01)
[7]
Fernandez D, 2010, DISCOV MED, V9, P173
[8]
Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus [J].
Hanlon, Peter ;
Avenell, Alison ;
Aucott, Lorna ;
Vickers, Mark A. .
ARTHRITIS RESEARCH & THERAPY, 2014, 16 (01)
[9]
Dysregulation of the TSC-mTOR pathway in human disease [J].
Inoki, K ;
Corradetti, MN ;
Guan, KL .
NATURE GENETICS, 2005, 37 (01) :19-24
[10]
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia [J].
Jerez, Andres ;
Clemente, Michael J. ;
Makishima, Hideki ;
Koskela, Hanna ;
LeBlanc, Francis ;
Ng, Kwok Peng ;
Olson, Thomas ;
Przychodzen, Bartlomiej ;
Afable, Manuel ;
Gomez-Segui, Ines ;
Guinta, Kathryn ;
Durkin, Lisa ;
Hsi, Eric D. ;
McGraw, Kathy ;
Zhang, Dan ;
Wlodarski, Marcin W. ;
Porkka, Kimmo ;
Sekeres, Mikkael A. ;
List, Alan ;
Mustjoki, Satu ;
Loughran, Thomas P. ;
Maciejewski, Jaroslaw P. .
BLOOD, 2012, 120 (15) :3048-3057